Zhu Min, former vice president of IMF: Domestic consumption, manufacturing and green transformation will become the growth drivers of China's economy. Recently, at the China 2024 Annual Meeting and the 22nd Financial Billboard, Zhu Min, former vice president of China International Economic Exchange Center, said that one of the three traditional locomotives of China's economic growth is infrastructure investment; The second is the real estate industry, and the third is export. The transformation of the whole economic structure needs a new growth impetus. Zhu Min said that this new growth driver is, first, based on domestic consumption, and second, insisting on doing a good job in domestic manufacturing and doing high technology; The third is green transformation. We will continue to take the road of sustainable development of green transformation in China and improve our core competitiveness.The monkeypox vaccine with independent intellectual property rights in China was approved for clinical use. On December 10th, the monkeypox vaccine jointly developed by China Bio-Beijing Institute of Biological Products and China Center for Disease Control and Prevention received the approval notice of drug clinical trial issued by National Medical Products Administration, and it was registered and classified as Class 1.2 innovative vaccine. The vaccine is an innovative vaccine independently developed by scientists in China with completely independent intellectual property rights, which is expected to play an important role in the prevention and control of diseases caused by monkeypox virus in China. (China Biology)By 2029, China will build about 10,000 superior specialties of traditional Chinese medicine. According to state administration of traditional chinese medicine, China will promote the construction of superior specialties of traditional Chinese medicine at different levels to further improve the clinical efficacy of traditional Chinese medicine. By 2029, the overall scale of superior specialties of traditional Chinese medicine will reach about 10,000. Recently, state administration of traditional chinese medicine issued opinions on accelerating the construction of superior specialties of traditional Chinese medicine, and put forward the requirements of strengthening the planning and layout of superior specialties of traditional Chinese medicine and promoting the construction of superior clusters of traditional Chinese medicine. (CCTV News)
Schlegel, Governor of the Swiss National Bank: We will continue to monitor inflationary pressure and adjust monetary policy to maintain price stability if necessary. Without today's interest rate cut, inflation expectations would be lower. The uncertainty of the future inflation path is still high. The medium-term inflationary pressure has dropped significantly.Tschudin, member of the management Committee of the Swiss National Bank: Due to the monetary easing policy, Swiss economic growth is expected to pick up slightly next year. Overseas developments are the main risks facing the Swiss economy.Institution: A small interest rate cut by the European Central Bank may have a neutral impact on euro credit. Analysts of Yuxin Bank said in a report that the European Central Bank is expected to announce a 25 basis point interest rate cut tonight, which should have a neutral impact on euro-denominated credit. Analysts said that if the central bank cuts interest rates by 50 basis points further, it is unlikely to be beneficial to euro credit, because it will raise concerns about economic growth in the euro zone. According to the data of LSEG Refinitiv, the possibility that the market expects the European Central Bank to cut interest rates by 25 basis points is 83%, while the possibility of cutting interest rates by 50 basis points is 17%. Yuxin Bank said that as the European Central Bank continues to cut interest rates, the euro credit spread may fluctuate slightly or tighten slightly in the coming months.
Rapdidus will start producing 2-nanometer chips in April next year. Dong Zhelang, president of Rapdidus, an advanced Japanese semiconductor foundry company, said that by the end of March 2025, Rapdidus will complete all the equipment setup required for trial production of 2-nanometer chips, and start the trial production line in April to actually produce 2-nanometer chips.Rapdidus will start producing 2-nanometer chips in April next year. Dong Zhelang, president of Rapdidus, an advanced Japanese semiconductor foundry company, said that by the end of March 2025, Rapdidus will complete all the equipment setup required for trial production of 2-nanometer chips, and start the trial production line in April to actually produce 2-nanometer chips.U.S. and cloth oil fell 0.3 USD in short term, and now they are reported at 70.08 USD/barrel and 73.50 USD/barrel respectively.
Strategy guide 12-13
Strategy guide 12-13
Strategy guide
12-13
Strategy guide
12-13